171 filings
Page 3 of 9
8-K
uf1e7g2l
3 Apr 13
Trius Appoints Seth Fischer to Its Board of Directors
12:00am
8-K
y1jh knncz3
25 Mar 13
Trius Announces Positive Results from Establish 2 Study of
12:00am
S-8
3pm9cpq 3j
13 Mar 13
Registration of securities for employees
12:00am
8-K
j7mm96tlg2yjy9pf
13 Mar 13
Departure of Directors or Certain Officers
12:00am
8-K
z3oi3l
12 Mar 13
Trius Therapeutics Reports 2012 Fourth Quarter and Full Year 2012 Financial Results
12:00am
424B5
61dwtzut0x29xiy2b
18 Jan 13
Prospectus supplement for primary offering
12:00am
424B5
0oi2ptirp
18 Jan 13
Prospectus supplement for primary offering
12:00am
8-K
jasexf
18 Jan 13
Trius Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
12:00am
424B5
pxhjv oqp9v
17 Jan 13
Prospectus supplement for primary offering
12:00am
424B5
xc64 f8eadn3d9zg33
17 Jan 13
Prospectus supplement for primary offering
12:00am
8-K
u8by5k
7 Jan 13
Tedizolid Receives Qualified Infectious Disease Product (Qidp) Designation from Fda
12:00am
424B5
byj4qfgaq4 027r
12 Dec 12
Prospectus supplement for primary offering
12:00am
8-K
5kweuiz7c922pdopwn
12 Dec 12
Other Events
12:00am
8-K
mac xx1bu9
5 Nov 12
Trius Therapeutics Reports 2012 Third Quarter Financial Results
12:00am
8-K
ye2ch0yllj02yt
9 Oct 12
Other Events
12:00am
424B5
ja23v 93r
9 Oct 12
Prospectus supplement for primary offering
12:00am
EFFECT
8t91j 3nnecahohhbs6h
11 Sep 12
Notice of effectiveness
12:00am